Effect of Beta-Blockers on Mortality after Myocardial Infarction in Adults with COPD

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
Jennifer Quint, clinical lecturer in epidemiology at the London School of Hygiene and Tropical Medicine, and Liam Smeeth, professor of clinical epidemiology at the London School of Hygiene and Tropical Medicine, discuss their BMJ study of UK COPD patients who have experienced a first myocardial infarction and the impact of beta-blocker therapy on mortality.

Related Articles
Even short-term treatment with nonsteroidal anti-inflammatory drugs is associated with significant increases in bleeding and cardiovascular event risk in patients receiving antithrombotic therapy after a heart attack.
The risk of heart attack is 8.5 times higher in the 2 hours following bursts of intense anger, suggests research from the University of Sydney.
While statins can effectively reduce cholesterol levels, a new study has found that the medications leave much to be desired in terms of substantially improving cardiovascular symptoms.
Women tend to experience more stress after acute myocardial infarction, which can translate to a worse recovery, according to a new study.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$